Clinical trial
Serum Concentration of HE4, a New Marker for Ovarian Cancer, Changes Little Throughout IVF Stimulation
NCT01576744 is registered in ClinicalTrials.gov with Turku University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Serum Concentration of HE4, a New Marker for Ovarian Cancer, Changes Little Throughout IVF Stimulation
- Lead sponsor
- Turku University Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 31, 2010
- Completion date
- Not reported
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
human epididymal secretory protein e4, ivf treatment